This biotechnology company develops Telomir-1, an oral small molecule therapeutic aimed at age reversal and chronic disease management. The compound functions by regulating essential metals, protecting telomere caps, and mitigating cellular damage pathways like oxidative stress and inflammation. Telomir-1 targets the fundamental drivers of aging at the cellular level rather than focusing solely on symptom management.
Funding
$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
As cells divide, telomeres, the protective caps on the ends of DNA strands, shorten, leading to DNA degradation and contributing to aging and age-related diseases. Current treatments primarily focus on managing symptoms rather than addressing the underlying causes of these conditions.
Solution
Telomir Pharmaceuticals is developing Telomir-1, an orally administered small molecule designed to address the root causes of aging and chronic diseases by modulating telomerase activity. Telomir-1 aims to repair and lengthen telomeres, thereby enhancing the fidelity of DNA replication and protecting stem cells. By regulating essential metals, defending against oxidative stress and DNA damage, and supporting immune resilience, Telomir-1 targets the core mechanisms of aging to promote healthier aging and overall vitality. The drug is currently under investigation as a potential therapeutic intervention against age-related inflammatory conditions.
Target Audience
The primary target audience includes individuals at risk of or affected by age-related diseases, as well as healthcare providers seeking treatments that address the underlying mechanisms of aging.
Features
- Oral small molecule formulation for convenient administration
- Modulates telomerase to promote telomere repair and lengthening
- Regulates key metals like iron and copper to reduce oxidative stress and inflammation
- Supports immune resilience and cellular longevity
- Designed to protect stem cells and sustain self-renewal
- Potential application in age-related inflammatory conditions
- Aims to reset the body's epigenetic clock and reverse DNA methylation